View allAll Photos Tagged Deflectors
Circa 1965(?) artist's concept of a Saturn V launch vehicle on the launch pad, with what appears to be a 'fixed' service structure to its right. The corner/treads of a crawler transporter are visible at the lower right of service structure, along with a flame deflector partially visible in the flame trench at the lower left of the image. Note also the ‘labeling’ of each stage - I suppose to facilitate the correct stacking/mating sequence. ;-)
I see the initials "RM" discreetly placed under the
GSE structures at lower right. Possibly a Renato Moncini work???
1337 Grosmont to Goathland freight service arrival into Goathland station. Notice there are no smoke deflectors on Repton.
Wrecks of German armoured vehicles.
In the foreground, a very late model of StuG III Ausf. G with some of the latest features such as coaxial MG-34, 80 mm thick front hull and left superstructure armour, shot deflector on commander's cupola, remote-controlled MG-34 on the roof, all metal return rollers.
Copyright Panzerwrecks, all rights reserved.
________
The Panzer Pictures Database | @PanzerDB (Twitter) | panzerdb.com
Hard iPad, iPhone and iPod Touch cases of this image available to buy online direct from my redbubble site.
iPad
www.redbubble.com/people/davidelder/works/9620167-apple-d...
iPhone & iPod
www.redbubble.com/people/davidelder/works/9620180-apple-d...
Looks at Links there more inside.
pharmacycode.com/msds/Thalidomide
History
Thalidomide was created by Grünenthal in 1953 and was used in the late 1950s and early 1960s as a "wonder drug" to treat morning sickness, headaches, coughs, insomnia and colds. Thalidomide was marketed in the UK under the name Distaval in 1958, and advertisements emphasized the drug's complete safety, using phrases such as “non-toxic” and “no known toxicity”.
However, in 1961 an Australian doctor, William McBride, wrote to the Lancet after noticing an increase in deformed babies being born at his hospital – all to mothers who had taken Thalidomide.
Between 1958 and 1962 tens of thousands of women throughout Europe found that the baby they were carrying unaccountably miscarried, or, worse, after they gave birth were told it was stillborn. Thousands more discovered that their babies had severe birth defects, missing arms, legs, or with severe reductions to these limbs, or even worse, damage to their internal organs, brain, heart, kidneys, intestines, genitals, etc. During 1962 record keepers began to count all of the children living who were born damaged by the drug. The only complete records are of those who survived long enough to participate in the national compensation schemes, which were established in Germany, Britain, Japan, Sweden and Australia in the 1970s. The difficulty in uncovering the full toll of the disaster begins with the unknown numbers of miscarriages and stillbirths (possibly up to ten times the number of live births), and the widespread practice of infanticide.
The Thalidomide injuries did not stop once the babies were born. At the age of fifty, the Thalidomide Trust’s records show that around half of all survivors are coping with chronic pain – mainly from muscles and joints (musculo-skeletal pain), largely as a result of the challenges of living with missing or damaged limbs. For many, their bodies are deteriorating far faster than able-bodied people. Several have been told words to the effect “your body is getting the problems of someone in their seventies”, which at forty to fifty years of age is not good news. At least a quarter are coping with developing neurological problems, tingling, numbness, and pain in their affected limbs. This means that a person may be holding a cup, for instance, and the next thing they know is it has fallen to the floor and broken, because of the numbness in their hand. For these survivors, the disaster is still slowly unfolding in their day-to-day lives.
Grünenthal scientists were not only negligent in failing to withdraw the drug when reports of problems came in, or for failing to test it according to the standards of the time, but more than most companies they were very well placed to anticipate the possibility that Thalidomide would cause birth defects.
Grünenthal initially denied claims that the drug hadn’t been extensively tested according to the standards of the time, but once the scandal became undeniable, they sought to deflect blame and limit damage.
In 1961 Thalidomide was eventually withdrawn after being found to be a teratogan - a cause of birth defects. 12 years later, the UK company Distillers Biochemicals Limited (now Diageo) – which was responsible for distributing the drug in the UK – reached a compensation settlement following a legal battle by the families of those affected.
Based on incomplete medical evidence and unrealistic expectations of Thalidomide survivors future needs this settlement has turned out to be at an inadequate level. With all Thalidomide survivors in the UK now over the age of 50, it is no longer sufficient to deal with their rising cost of living, and the dramatic deterioration of their health.
To this day, Grünenthal have never accepted responsibility for the suffering caused by Thalidomide. On September 1st 2012, The Grünenthal Group released a statement containing an apology, stating that it "regrets" the consequences of the drug, which led to babies being born without limbs during the 1950s and 1960s. Although the statement was welcomed by some Thalidomide survivors, it is still not an acceptance of responsibility. They just want to live a comfortable life, and that means Grünenthal should be held accountable and pay for their mistake financially.
Spanish
Historia
La talidomida fue creado por Grünenthal en 1953 y fue utilizado a finales de 1950 y principios de 1960 como una "droga milagrosa" para el tratamiento de las náuseas, dolores de cabeza, tos, insomnio y resfriados. La talidomida fue comercializada en el Reino Unido bajo el nombre Distaval en 1958, y destacó los anuncios de seguridad completa del medicamento, utilizando frases como "no tóxico" y "no hay toxicidad conocida".
Sin embargo, en 1961 un médico australiano, William McBride, escribió a la revista The Lancet después de notar un aumento en los bebés que nacen deformes en su hospital - todo a las madres que habían tomado Talidomida.
Entre 1958 y 1962, decenas de miles de mujeres de toda Europa descubrieron que el bebé que llevaban inexplicablemente abortado, o, peor aún, después de dar a luz se les dijo que estaba muerto. Miles de personas descubrieron que sus bebés nacieron con defectos congénitos graves, los brazos, las piernas, que faltan o con reducciones severas a estos miembros, o peor aún, el daño a sus órganos internos, cerebro, corazón, riñones, intestinos, genitales, etc Durante 1962 guardianes de los registros empezó a contar toda la vida los niños que nacieron dañado por la droga. Los únicos registros completos son de los que sobrevivieron lo suficiente como para participar en los sistemas nacionales de indemnización, que se establecieron en Alemania, Gran Bretaña, Japón, Suecia y Australia en la década de 1970. La dificultad para descubrir el número de víctimas del desastre comienza con los números desconocidos de abortos involuntarios y mortinatos (posiblemente hasta diez veces el número de nacidos vivos), y la práctica generalizada del infanticidio.
Las lesiones de la talidomida no se detuvo una vez que los bebés nacieron. A la edad de cincuenta años, los registros de la confianza talidomida muestran que cerca de la mitad de todos los sobrevivientes están lidiando con el dolor crónico - principalmente de músculos y articulaciones (dolor musculoesquelético), en gran parte como resultado de los desafíos de vivir con la falta o ramas dañadas. Para muchos, sus cuerpos se deterioran mucho más rápido que las personas sanas. Algunos han dicho palabras en el sentido de "su cuerpo está recibiendo los problemas de alguien en los setenta", que a los cuarenta o cincuenta años de edad no es una buena noticia. Al menos una cuarta están lidiando con el desarrollo de problemas neurológicos, hormigueo, entumecimiento y dolor en las extremidades afectadas. Esto significa que una persona puede ser la celebración de una taza, por ejemplo, y lo siguiente que sé es que ha caído al suelo y se rompe, debido a la sensación de adormecimiento en la mano. Para estos sobrevivientes, el desastre está siendo poco a poco se desarrolla en su día a día.
Grünenthal científicos no sólo fueron negligentes al no haber retirado la droga cuando los informes de problemas de vino, o por no probarlo de acuerdo a los estándares de la época, pero más que la mayoría de las empresas que estaban muy bien situados para prever la posibilidad de que la talidomida haría causar defectos de nacimiento.
Grünenthal inicialmente negó las acusaciones de que el medicamento no ha sido ampliamente probado de acuerdo con los estándares de la época, pero una vez que el escándalo se hizo innegable, trataron de desviar la culpa y limitar el daño.
En 1961, la talidomida fue finalmente retirada después de haber sido encontrado para ser un teratogan - una de las causas de los defectos congénitos. 12 años después, el Reino Unido, Distillers Company Limited (ahora Bioquímicos Diageo) - encargada de la distribución de la droga en el Reino Unido - llegó a un acuerdo de compensación después de una batalla legal por las familias de los afectados.
Sobre la base de evidencia incompleta médica y expectativas poco realistas de la talidomida futuro sobrevivientes necesita esta solución ha resultado ser en un nivel adecuado. Con todos los sobrevivientes de la talidomida en el Reino Unido ahora más de 50 años de edad, ya no es suficiente para hacer frente a su creciente costo de vida, y el dramático deterioro de su salud.
A día de hoy, Grünenthal nunca ha aceptado la responsabilidad por el sufrimiento causado por la talidomida. El 1 de septiembre de 2012, el Grupo Grünenthal emitió una declaración que contenga una disculpa, diciendo que "lamenta" las consecuencias de la droga, lo que llevó a los bebés que nacen sin extremidades durante los años 1950 y 1960. Aunque la declaración fue bien recibida por algunos sobrevivientes de la talidomida, no es todavía una aceptación de responsabilidad. Ellos sólo quieren vivir una vida cómoda, y eso quiere decir Grünenthal deben rendir cuentas y pagar por su error financieramente.
Italian
Storia
La talidomide è stato creato da Grünenthal nel 1953 ed è stato utilizzato alla fine del 1950 e 1960 come un "farmaco miracoloso" per curare la malattia di mattina, mal di testa, tosse, insonnia e raffreddori. La talidomide è stato commercializzato nel Regno Unito con il nome di Distaval nel 1958, e la pubblicità ha sottolineato sicurezza del farmaco, con frasi come "non tossico" e "nessuna tossicità conosciuto".
Tuttavia, nel 1961 un medico australiano, William McBride, ha scritto al Lancet dopo aver notato un aumento delle nascite di bimbi malformati essendo nati a suo ospedale - tutti da madri che avevano assunto talidomide.
Tra il 1958 e il 1962 decine di migliaia di donne in tutta Europa ha scoperto che il bambino che portavano inspiegabilmente abortito, o, peggio, dopo che ha dato alla luce hanno detto che era morto. Altre migliaia hanno scoperto che i loro bambini hanno gravi difetti di nascita, braccia, gambe, mancanti o con gravi riduzioni a queste arti, o peggio ancora, danni ai loro organi interni, cervello, cuore, reni, intestino, genitali, ecc Nel 1962 custodi record cominciò a contare tutta la vita i bambini che sono nati danneggiati dal farmaco. Le uniche registrazioni complete sono di coloro che sono sopravvissuti abbastanza a lungo per partecipare ai sistemi di indennizzo nazionali, che sono stati stabiliti in Germania, Gran Bretagna, Giappone, Svezia e Australia nel 1970. La difficoltà nello scoprire il bilancio del disastro inizia con i numeri sconosciuti di aborti spontanei e nati morti (forse fino a dieci volte il numero di nati vivi), e la pratica diffusa di infanticidio.
Le lesioni Talidomide non si è fermata una volta che i bambini sono nati. All'età di 50, del Trust talidomide i tabulati mostrano che circa la metà di tutti i sopravvissuti stanno affrontando con dolore cronico - principalmente da muscoli e le articolazioni (il dolore muscoloscheletrico), soprattutto a causa delle sfide della vita con mancanti o arti danneggiati. Per molti, i loro corpi si stanno deteriorando molto più veloce di persone abili. Molti hanno detto parole per l'effetto "il tuo corpo è sempre il problema di qualcuno nei loro anni settanta", che a 40-50 anni di età non è una buona notizia. Almeno un quarto stanno affrontando con lo sviluppo di problemi neurologici, formicolio, intorpidimento e dolore a carico degli arti colpiti. Ciò significa che una persona può essere in possesso di un tazza, per esempio, e la prossima cosa che so è che è caduto a terra e rotto, a causa del torpore in mano. Per questi sopravvissuti, il disastro è ancora lentamente svolgendo nel loro giorno per giorno la vita.
Grünenthal scienziati non erano solo negligenza nel non ritirare il farmaco quando i report di problemi è venuto in, o per non aver testarlo secondo gli standard del tempo, ma più che la maggior parte delle aziende erano molto ben disposti ad anticipare la possibilità che Thalidomide avrebbe causare difetti di nascita.
Grünenthal inizialmente smentito che il farmaco non era stato ampiamente testati secondo gli standard del tempo, ma una volta che lo scandalo è diventata innegabile, hanno cercato di deviare la colpa e di limitare i danni.
Nel 1961 talidomide è stata infine ritirata dopo essere stato trovato per essere un teratogan - una causa di difetti di nascita. 12 anni dopo, i Distillers Company Limited, Regno Unito Biochemicals (ora Diageo) - incaricata di distribuire il farmaco nel Regno Unito - ha raggiunto un accordo di compensazione a seguito di una battaglia legale da parte delle famiglie delle persone colpite.
Sulla base di prove mediche incomplete e le aspettative non realistiche del futuro Thalidomide sopravvissuti ha bisogno di questa soluzione si è rivelata essere ad un livello insufficiente. Con tutti i sopravvissuti Talidomide nel Regno Unito ora di età superiore ai 50 anni, non è più sufficiente per affrontare la loro crescente costo della vita, e il drammatico deterioramento della loro salute.
Fino ad oggi, la Grünenthal non hanno mai accettato la responsabilità per la sofferenza causata dal talidomide. Il 1 ° settembre 2012, il Gruppo Grünenthal ha rilasciato una dichiarazione che contiene delle scuse, affermando che esso "deplora" le conseguenze della droga, che ha portato a bambini nati senza arti nel corso del 1950 e 1960. Anche se la dichiarazione è stata accolta da alcuni sopravvissuti talidomide, non è ancora una assunzione di responsabilità. Vogliono solo vivere una vita comoda, e questo significa che Grünenthal dovrebbero essere ritenuti responsabili e pagare per il loro errore finanziario.
History
Thalidomide was created by Grünenthal in 1953 and was used in the late 1950s and early 1960s as a "wonder drug" to treat morning sickness, headaches, coughs, insomnia and colds. Thalidomide was marketed in the UK under the name Distaval in 1958, and advertisements emphasized the drug's complete safety, using phrases such as “non-toxic” and “no known toxicity”.
However, in 1961 an Australian doctor, William McBride, wrote to the Lancet after noticing an increase in deformed babies being born at his hospital – all to mothers who had taken Thalidomide.
Between 1958 and 1962 tens of thousands of women throughout Europe found that the baby they were carrying unaccountably miscarried, or, worse, after they gave birth were told it was stillborn. Thousands more discovered that their babies had severe birth defects, missing arms, legs, or with severe reductions to these limbs, or even worse, damage to their internal organs, brain, heart, kidneys, intestines, genitals, etc. During 1962 record keepers began to count all of the children living who were born damaged by the drug. The only complete records are of those who survived long enough to participate in the national compensation schemes, which were established in Germany, Britain, Japan, Sweden and Australia in the 1970s. The difficulty in uncovering the full toll of the disaster begins with the unknown numbers of miscarriages and stillbirths (possibly up to ten times the number of live births), and the widespread practice of infanticide.
The Thalidomide injuries did not stop once the babies were born. At the age of fifty, the Thalidomide Trust’s records show that around half of all survivors are coping with chronic pain – mainly from muscles and joints (musculo-skeletal pain), largely as a result of the challenges of living with missing or damaged limbs. For many, their bodies are deteriorating far faster than able-bodied people. Several have been told words to the effect “your body is getting the problems of someone in their seventies”, which at forty to fifty years of age is not good news. At least a quarter are coping with developing neurological problems, tingling, numbness, and pain in their affected limbs. This means that a person may be holding a cup, for instance, and the next thing they know is it has fallen to the floor and broken, because of the numbness in their hand. For these survivors, the disaster is still slowly unfolding in their day-to-day lives.
Grünenthal scientists were not only negligent in failing to withdraw the drug when reports of problems came in, or for failing to test it according to the standards of the time, but more than most companies they were very well placed to anticipate the possibility that Thalidomide would cause birth defects.
Grünenthal initially denied claims that the drug hadn’t been extensively tested according to the standards of the time, but once the scandal became undeniable, they sought to deflect blame and limit damage.
In 1961 Thalidomide was eventually withdrawn after being found to be a teratogan - a cause of birth defects. 12 years later, the UK company Distillers Biochemicals Limited (now Diageo) – which was responsible for distributing the drug in the UK – reached a compensation settlement following a legal battle by the families of those affected.
Based on incomplete medical evidence and unrealistic expectations of Thalidomide survivors future needs this settlement has turned out to be at an inadequate level. With all Thalidomide survivors in the UK now over the age of 50, it is no longer sufficient to deal with their rising cost of living, and the dramatic deterioration of their health.
To this day, Grünenthal have never accepted responsibility for the suffering caused by Thalidomide. On September 1st 2012, The Grünenthal Group released a statement containing an apology, stating that it "regrets" the consequences of the drug, which led to babies being born without limbs during the 1950s and 1960s. Although the statement was welcomed by some Thalidomide survivors, it is still not an acceptance of responsibility. They just want to live a comfortable life, and that means Grünenthal should be held accountable and pay for their mistake financially.
Spanish
Historia
La talidomida fue creado por Grünenthal en 1953 y fue utilizado a finales de 1950 y principios de 1960 como una "droga milagrosa" para el tratamiento de las náuseas, dolores de cabeza, tos, insomnio y resfriados. La talidomida fue comercializada en el Reino Unido bajo el nombre Distaval en 1958, y destacó los anuncios de seguridad completa del medicamento, utilizando frases como "no tóxico" y "no hay toxicidad conocida".
Sin embargo, en 1961 un médico australiano, William McBride, escribió a la revista The Lancet después de notar un aumento en los bebés que nacen deformes en su hospital - todo a las madres que habían tomado Talidomida.
Entre 1958 y 1962, decenas de miles de mujeres de toda Europa descubrieron que el bebé que llevaban inexplicablemente abortado, o, peor aún, después de dar a luz se les dijo que estaba muerto. Miles de personas descubrieron que sus bebés nacieron con defectos congénitos graves, los brazos, las piernas, que faltan o con reducciones severas a estos miembros, o peor aún, el daño a sus órganos internos, cerebro, corazón, riñones, intestinos, genitales, etc Durante 1962 guardianes de los registros empezó a contar toda la vida los niños que nacieron dañado por la droga. Los únicos registros completos son de los que sobrevivieron lo suficiente como para participar en los sistemas nacionales de indemnización, que se establecieron en Alemania, Gran Bretaña, Japón, Suecia y Australia en la década de 1970. La dificultad para descubrir el número de víctimas del desastre comienza con los números desconocidos de abortos involuntarios y mortinatos (posiblemente hasta diez veces el número de nacidos vivos), y la práctica generalizada del infanticidio.
Las lesiones de la talidomida no se detuvo una vez que los bebés nacieron. A la edad de cincuenta años, los registros de la confianza talidomida muestran que cerca de la mitad de todos los sobrevivientes están lidiando con el dolor crónico - principalmente de músculos y articulaciones (dolor musculoesquelético), en gran parte como resultado de los desafíos de vivir con la falta o ramas dañadas. Para muchos, sus cuerpos se deterioran mucho más rápido que las personas sanas. Algunos han dicho palabras en el sentido de "su cuerpo está recibiendo los problemas de alguien en los setenta", que a los cuarenta o cincuenta años de edad no es una buena noticia. Al menos una cuarta están lidiando con el desarrollo de problemas neurológicos, hormigueo, entumecimiento y dolor en las extremidades afectadas. Esto significa que una persona puede ser la celebración de una taza, por ejemplo, y lo siguiente que sé es que ha caído al suelo y se rompe, debido a la sensación de adormecimiento en la mano. Para estos sobrevivientes, el desastre está siendo poco a poco se desarrolla en su día a día.
Grünenthal científicos no sólo fueron negligentes al no haber retirado la droga cuando los informes de problemas de vino, o por no probarlo de acuerdo a los estándares de la época, pero más que la mayoría de las empresas que estaban muy bien situados para prever la posibilidad de que la talidomida haría causar defectos de nacimiento.
Grünenthal inicialmente negó las acusaciones de que el medicamento no ha sido ampliamente probado de acuerdo con los estándares de la época, pero una vez que el escándalo se hizo innegable, trataron de desviar la culpa y limitar el daño.
En 1961, la talidomida fue finalmente retirada después de haber sido encontrado para ser un teratogan - una de las causas de los defectos congénitos. 12 años después, el Reino Unido, Distillers Company Limited (ahora Bioquímicos Diageo) - encargada de la distribución de la droga en el Reino Unido - llegó a un acuerdo de compensación después de una batalla legal por las familias de los afectados.
Sobre la base de evidencia incompleta médica y expectativas poco realistas de la talidomida futuro sobrevivientes necesita esta solución ha resultado ser en un nivel adecuado. Con todos los sobrevivientes de la talidomida en el Reino Unido ahora más de 50 años de edad, ya no es suficiente para hacer frente a su creciente costo de vida, y el dramático deterioro de su salud.
A día de hoy, Grünenthal nunca ha aceptado la responsabilidad por el sufrimiento causado por la talidomida. El 1 de septiembre de 2012, el Grupo Grünenthal emitió una declaración que contenga una disculpa, diciendo que "lamenta" las consecuencias de la droga, lo que llevó a los bebés que nacen sin extremidades durante los años 1950 y 1960. Aunque la declaración fue bien recibida por algunos sobrevivientes de la talidomida, no es todavía una aceptación de responsabilidad. Ellos sólo quieren vivir una vida cómoda, y eso quiere decir Grünenthal deben rendir cuentas y pagar por su error financieramente.
Italian
Storia
La talidomide è stato creato da Grünenthal nel 1953 ed è stato utilizzato alla fine del 1950 e 1960 come un "farmaco miracoloso" per curare la malattia di mattina, mal di testa, tosse, insonnia e raffreddori. La talidomide è stato commercializzato nel Regno Unito con il nome di Distaval nel 1958, e la pubblicità ha sottolineato sicurezza del farmaco, con frasi come "non tossico" e "nessuna tossicità conosciuto".
Tuttavia, nel 1961 un medico australiano, William McBride, ha scritto al Lancet dopo aver notato un aumento delle nascite di bimbi malformati essendo nati a suo ospedale - tutti da madri che avevano assunto talidomide.
Tra il 1958 e il 1962 decine di migliaia di donne in tutta Europa ha scoperto che il bambino che portavano inspiegabilmente abortito, o, peggio, dopo che ha dato alla luce hanno detto che era morto. Altre migliaia hanno scoperto che i loro bambini hanno gravi difetti di nascita, braccia, gambe, mancanti o con gravi riduzioni a queste arti, o peggio ancora, danni ai loro organi interni, cervello, cuore, reni, intestino, genitali, ecc Nel 1962 custodi record cominciò a contare tutta la vita i bambini che sono nati danneggiati dal farmaco. Le uniche registrazioni complete sono di coloro che sono sopravvissuti abbastanza a lungo per partecipare ai sistemi di indennizzo nazionali, che sono stati stabiliti in Germania, Gran Bretagna, Giappone, Svezia e Australia nel 1970. La difficoltà nello scoprire il bilancio del disastro inizia con i numeri sconosciuti di aborti spontanei e nati morti (forse fino a dieci volte il numero di nati vivi), e la pratica diffusa di infanticidio.
Le lesioni Talidomide non si è fermata una volta che i bambini sono nati. All'età di 50, del Trust talidomide i tabulati mostrano che circa la metà di tutti i sopravvissuti stanno affrontando con dolore cronico - principalmente da muscoli e le articolazioni (il dolore muscoloscheletrico), soprattutto a causa delle sfide della vita con mancanti o arti danneggiati. Per molti, i loro corpi si stanno deteriorando molto più veloce di persone abili. Molti hanno detto parole per l'effetto "il tuo corpo è sempre il problema di qualcuno nei loro anni settanta", che a 40-50 anni di età non è una buona notizia. Almeno un quarto stanno affrontando con lo sviluppo di problemi neurologici, formicolio, intorpidimento e dolore a carico degli arti colpiti. Ciò significa che una persona può essere in possesso di un tazza, per esempio, e la prossima cosa che so è che è caduto a terra e rotto, a causa del torpore in mano. Per questi sopravvissuti, il disastro è ancora lentamente svolgendo nel loro giorno per giorno la vita.
Grünenthal scienziati non erano solo negligenza nel non ritirare il farmaco quando i report di problemi è venuto in, o per non aver testarlo secondo gli standard del tempo, ma più che la maggior parte delle aziende erano molto ben disposti ad anticipare la possibilità che Thalidomide avrebbe causare difetti di nascita.
Grünenthal inizialmente smentito che il farmaco non era stato ampiamente testati secondo gli standard del tempo, ma una volta che lo scandalo è diventata innegabile, hanno cercato di deviare la colpa e di limitare i danni.
Nel 1961 talidomide è stata infine ritirata dopo essere stato trovato per essere un teratogan - una causa di difetti di nascita. 12 anni dopo, i Distillers Company Limited, Regno Unito Biochemicals (ora Diageo) - incaricata di distribuire il farmaco nel Regno Unito - ha raggiunto un accordo di compensazione a seguito di una battaglia legale da parte delle famiglie delle persone colpite.
Sulla base di prove mediche incomplete e le aspettative non realistiche del futuro Thalidomide sopravvissuti ha bisogno di questa soluzione si è rivelata essere ad un livello insufficiente. Con tutti i sopravvissuti Talidomide nel Regno Unito ora di età superiore ai 50 anni, non è più sufficiente per affrontare la loro crescente costo della vita, e il drammatico deterioramento della loro salute.
Fino ad oggi, la Grünenthal non hanno mai accettato la responsabilità per la sofferenza causata dal talidomide. Il 1 ° settembre 2012, il Gruppo Grünenthal ha rilasciato una dichiarazione che contiene delle scuse, affermando che esso "deplora" le conseguenze della droga, che ha portato a bambini nati senza arti nel corso del 1950 e 1960. Anche se la dichiarazione è stata accolta da alcuni sopravvissuti talidomide, non è ancora una assunzione di responsabilità. Vogliono solo vivere una vita comoda, e questo significa che Grünenthal dovrebbero essere ritenuti responsabili e pagare per il loro errore finanziario.
Royal Scot Lancashire Witch with an odd smoke deflector arrangement...this loco was renamed to 3rd Carabinier and rebuilt with taper boiler in Aug 1943.
Armee de L'Air Boeing KC-135FR with left rudder deflected on entering Runway 10 at Dublin Airport Ireland.
November 22nd, 1966
56D Mirfield mpd
A guest at Mirfield during its last weeks before closure was Britannia Pacific 70004 (with no indication on the smoke deflectors of its William Shakespeare nameplate), a Stockport engine.
Ref B1-30
Chibi Brown Twank. Original Twank design by Atavism.
Equipped with Deflector Domes, Flare Tube, Floodlight, and Antenna
Hans van Eijsden Photography, The Netherlands
Lens: Canon EF 85mm f/1.2L II USM on full frame.
Light: Minimalistic setup with the Elinchrom ELC 1000 through a strip box with silver deflector without grid from the right. Elinchrom ELC 500 through a dish on the background. I measured the light with the Sekonic L-758DR.
Postprocessing: Some local adjustment curves, some local cloning.
Portfolio: www.hansvaneijsden.com
Facebook Page: www.facebook.com/hansvaneijsdenphotography
USS CORAL SEA was supporting carrier qualifications at the time for pilots. I was a midshipman aboard the carrier.
The picture was scanned from a 110-format slide.
974 07 00 - at sea - CA - 052 USS CORAL SEA (CVA-43) at sea SOCAL - F-4 unknown SN and BuNo but flap nr 11 - on starboard catapult with jet blast deflector raised
SOUTH CHINA SEA (Sept. 12, 2021) Sailors clean a jet blast deflector on the flight deck of Nimitz-class aircraft carrier USS Carl Vinson (CVN 70). Carl Vinson Carrier Strike Group is on a scheduled deployment in the U.S. 7th Fleet to enhance interoperability through alliances and partnerships while serving as a ready-response force in support of a free and open Indo-Pacific region. (U.S. Navy photo by Mass Communication Specialist 3rd Class Nicholas Carter)
LNER Class V2 2-6-2 no. 60813 (fitted with small chimney smoke deflectors) at Edinburgh (St Margarets) shed. I believe the A3 behind is no. 60041 "Salmon Trout". That day, 30th July 1964, my brother and I had permits to visit the sheds at Bathgate, Dalry Road and St Margarets. The shed was actually on both sides of the main line and this photo was taken from the south side (my photo MR_0014r was from the north side). I remember being escorted across what seemed to me a very long wooden board walk across the main lines. In the Ian Allan "The British Locomotive Shed Directory" it does say "Great care should be taken to obey the warning signals when using the boarded crossing over the main line from the roundhouse to the main shed building".
Quoting Smithsonian National Air and Space Museum | Vought OS2U-3 Kingfisher:
The Kingfisher was the U.S. Navy's primary ship-based, scout and observation aircraft during World War II. Revolutionary spot welding techniques gave it a smooth, non-buckling fuselage structure. Deflector plate flaps that hung from the wing's trailing edge and spoiler-augmented ailerons functioned like extra flaps to allow slower landing speeds. Most OS2Us operated in the Pacific, where they rescued many downed airmen, including World War I ace Eddie Rickenbacker and the crew of his B-17 Flying Fortress.
In March 1942, this airplane was assigned to the battleship USS Indiana. It later underwent a six-month overhaul in California, returned to Pearl Harbor, and rejoined the Indiana in March 1944. Lt. j.g. Rollin M. Batten Jr. was awarded the Navy Cross for making a daring rescue in this airplane under heavy enemy fire on July 4, 1944.
Transferred from the United States Navy.
Manufacturer:
Vought-Sikorsky Aircraft Division
Date:
1937
Country of Origin:
United States of America
Dimensions:
Overall: 15ft 1 1/8in. x 33ft 9 1/2in., 4122.6lb., 36ft 1 1/16in. (460 x 1030cm, 1870kg, 1100cm)
Materials:
Wings covered with fabric aft of the main spar
Physical Description:
Two-seat monoplane, deflector plate flaps hung from the trailing edge of the wing, ailerons drooped at low airspeeds to function like extra flaps, spoilers.
• • • • •
Quoting Smithsonian National Air and Space Museum | Boeing B-29 Superfortress "Enola Gay":
Boeing's B-29 Superfortress was the most sophisticated propeller-driven bomber of World War II and the first bomber to house its crew in pressurized compartments. Although designed to fight in the European theater, the B-29 found its niche on the other side of the globe. In the Pacific, B-29s delivered a variety of aerial weapons: conventional bombs, incendiary bombs, mines, and two nuclear weapons.
On August 6, 1945, this Martin-built B-29-45-MO dropped the first atomic weapon used in combat on Hiroshima, Japan. Three days later, Bockscar (on display at the U.S. Air Force Museum near Dayton, Ohio) dropped a second atomic bomb on Nagasaki, Japan. Enola Gay flew as the advance weather reconnaissance aircraft that day. A third B-29, The Great Artiste, flew as an observation aircraft on both missions.
Transferred from the United States Air Force.
Manufacturer:
Date:
1945
Country of Origin:
United States of America
Dimensions:
Overall: 900 x 3020cm, 32580kg, 4300cm (29ft 6 5/16in. x 99ft 1in., 71825.9lb., 141ft 15/16in.)
Materials:
Polished overall aluminum finish
Physical Description:
Four-engine heavy bomber with semi-monoqoque fuselage and high-aspect ratio wings. Polished aluminum finish overall, standard late-World War II Army Air Forces insignia on wings and aft fuselage and serial number on vertical fin; 509th Composite Group markings painted in black; "Enola Gay" in black, block letters on lower left nose.
At Launch Pad 39B at NASA's Kennedy Space Center in Florida, cranes lower large segments of the support hardware for a new flame deflector into place in the flame trench. Construction workers weld the structures together. The new flame deflector will be positioned about six feet south of the shuttle-era flame deflector’s position. During liftoff of NASA’s Space Launch System, the rocket’s flame and energy will be diverted to the north side of the flame trench. The north side of the deflector will be protected by a NASA standard coating. The south side of the deflector will not be slanted and will have no lining. The new design will provide easier access for inspection, maintenance and repair. The Ground Systems Development and Operations (GSDO) Program at Kennedy is managing the installation of the flame deflector for Exploration Mission 1, deep space missions, and NASA's Journey to Mars. Photo credit: NASA/Kim Shiflett
@ The Dog & Pony Show ~ Sept. 29 - Oct. 23
A sort of armor for the scouting companion of a primal hunter. It may not be the most efficient at deflecting blows, but at the very least, it's emergency rations for caveman's best friend.
These bone pieces are for Teeglepet Dogs only! They are fitted to the following dogs:
• Mutt
• Labrador
• German Shepherd
• Wolf
Two colors are included per size: Aged bone and Black bone. The headpiece and backpieces are separate objects so you can add or remove them with ease.
To use, simply rez alongside your Teegle dog and link them together. This WILL raise the land impact for the animesh dog, doubling the land cost, so it is best to use these bones on a dog you intend to wear. Unless of course you have the land impact to spare!
Mod / Copy / No Trans
More from me ♥
Copyright © John G. Lidstone, all rights reserved.
You are warned: DO NOT STEAL or RE-POST THIS PHOTO.
It is an offence under law if you remove my copyright marking, or post this image anywhere else without my express written permission.
If you do, and I find out, you WILL be reported for copyright infringement action to the host platform and/or group applicable.
The same applies to all of my images.
My copyright is also embedded in the image metadata.
Winterthur, Switzerland, January 2011
Elinchrom Quadra RX. Quadra A head, camera left, with 70cm bare Deep Octa (just a deflector, no baffles). This was my first real outing with Quadras. Must admit I enjoy using them more and more.
• NIKON D700 • ¹⁄₂₅₀ sec at f/4.5 (0 EV) • ISO 200 • Pattern metering • Manual • no flash • 70-200 mm f/2.8 @ 200 mm •
• NIKON D700 // AF-S Nikkor 70-200mm f/2.8G ED VR II at 200 mm (VR Off) // Exposure - 1/250 @ f/4.5 (0EV), ISO 200 // Multi-segment metering, Manual exposure // White Balance - 5560K // AF - On, AF-C, Dynamic Area (9 points), Primary AF Point - C11, Used AF Point - C11 // Shooting Mode - Single-Frame // FOV - 10.1 deg (2.10 m), Focus Distance - 11.89 m, DOF - 0.94 m (11.43 - 12.37), Hyperfocal - 295.84 m // Nikon NEF Compressed, 14bit, Adobe RGB •
2011-01-16-0120-4130
Please do not use this image on websites, blogs or other media without my explicit permission.
Copyright © 2011 yOOrek
Bernice In B/W
Hans van Eijsden Photography, The Netherlands
Lens: Canon EF 85mm f/1.2L II USM on full frame.
Light: Simple setup with one Elinchrom ELB 400 + Action Head through a Deep Octa with silver deflector and inner diffuser from the front-side, light from the back is ambient light. I lowered the power with the Elinchrom Skyport HS trigger, so I could open the lens almost completely.
Postprocessing: Some local adjustment curves, BW conversion, grain.
Portfolio: www.hansvaneijsden.com
Facebook Page: www.facebook.com/hansvaneijsdenphotography
Fleet No.: F18
Reg. No.: BVT 417
Manufacturer: Daewoo Bus Corp.
Model: BH117H "Royal Cruistar"
Engine: Daewoo DE12Tis
*Specifications are subjected for verification and may be changed without prior notice.
Light Class All Purpose Starfighter.
Armament :
Twin Proton Cannons
Twin Laser Cannons
Deflector Shields
Hyperdrive Class 1.5
I think that Maisie measures how much she likes her clothes on some sort of spinning scale. This outfit was actually bought for the wedding that we attended a couple of weeks ago and she was wearing it for my Week 18 photograph. It must be a favourite though as she is wearing it to a friend's birthday party this afternoon. Happy Birthday Sofia.
It's been a while since I produced anything from the studio so it was nice to be able to get back in there for a play. I'm not sure who was enjoying it more!
Strobist:
Ranger A Head, B port at 5.0, 70cm white maxisoft with silver deflector and sock, above camera.
Ranger Quadra A Head, A port at 4.0, 135 Midi Octa with both diffusers, camera left.
Ranger Quadra A Head, B port at 2.8, 130x50 strip with both diffusers, rear camera left
Ranger Quadra A Head, B port at 2.8, 130x50 strip with both diffusers, rear camera right
RX600, 3.0, 21cm reflector and barn doors, rear camera left to light white background.
RX600, 3.0, 21cm reflector and barn doors, rear camera right to light white background.
Triggered by Skyport Speed.
An unidentified Saturn V S-IC stage undergoing static test firing in the B-1/B-2 test stand, Mississippi Test Facility (MTF), 1967.
Based on the year, and if the (online) content of “Saturn Illustrated Chronology” for that year
history.nasa.gov/MHR-5/part-8.htm
is comprehensive, then (if I’m reading it correctly) it’s either S-IC-T, S-IC-4 (Apollo 9) or S-IC-5 (Apollo 10).
Very interesting photographic history of the test stand:
crgis.ndc.nasa.gov/historic/B-1/B-2_Test_Stand
Excellent F-1 reading:
www.thespacereview.com/article/3724/1
Credit: The Space Review website
"Buzz has reached the bottom rung of the ladder and is about the jump down to the footpad. As he said at the moment Neil took this picture, "Okay. I'm going to leave that one foot up there and both hands down to about the fourth rung up." The thermal shroud protecting the U.S. flag that Neil and Buzz deploy during the EVA can be seen on the underside of the lefthand ladder rail. See, also, NASA photo S69-38755,
www.hq.nasa.gov/alsj/mccraw.gif
which shows the flag on a LM mockup in Houston."
www.hq.nasa.gov/alsj/a11/AS11-40-5868.jpg
All above credit the ALSJ.
Also:
"Astronaut Edwin E. Aldrin Jr., lunar module pilot, descends the steps of the Lunar Module (LM) ladder as he prepares to walk on the moon. He had just egressed the LM. This photograph was taken by astronaut Neil A. Armstrong, commander, with a 70mm lunar surface camera during the Apollo 11 extravehicular activity (EVA). While Armstrong and Aldrin descended in the LM "Eagle" to explore the moon, astronaut Michael Collins, command module pilot, remained with the Command and Service Modules (CSM) in lunar orbit."
The M-Wing was a ship famous for its heavy armor and weaponry. However, when deflector shields came into use on small ships it was rendered obsolete. Yet now a shadowy mechanic has switched out the clunky armor for newer deflector shields, creating one of the most deadly ships in the galaxy.
And here is engine 207 (aka Boyne) at Amiens Street Station (now Connolly Station) in Dublin, being emptied of cinders, clinkers, ash...
Date: Sunday, 21 June 1964
NLI Ref.: ODEA 39/38
After a day of hard work I took Sera Yosta, my most beautiful lens and my Elinchrom light outside to the streets of Amsterdam, just to see what light can do. The temperature was quite high here in The Netherlands, 14 degrees Celcius in mid-december! So, the perfect moment to make some simple clicks.
As light I used the ELB400 & Elinchrom Deep Octa with translucent deflector and inner diffuser.
Lens: Canon EF 85mm f/1.2L II USM on full frame.
Hans van Eijsden Photography, The Netherlands
Postprocessing: Some local adjustment curves.
Portfolio: www.hansvaneijsden.com
Facebook Page: www.facebook.com/hansvaneijsdenphotography
Hans van Eijsden Photography, The Netherlands
Model: Kristel de Sera
Lens: Canon EF 85mm f/1.2L II USM on full frame.
Light: An Elinchrom ELB 400 with one HS head as key light from the front into an Elinchrom Deep Octa with silver deflector and with inner diffusor, triggered via the Skyport Plus HS. Light from the back is ambient light.
Postprocessing: Some local adjustment curves, some local cloning, greyscale conversion, toning, added grain.
Portfolio: www.hansvaneijsden.com
Facebook Page: www.facebook.com/hansvaneijsdenphotography
Complete with accessory side window wind deflector and rear window wind deflector, but apparently not a fuel cap. Modern Regularity Mallala
It would have been great to have LNER A3 Pacific 60103 Flying Scotsman in that line-up at Barrow Hill last week, particularly in this British Railways livery. This looked very early 1960s even down to its unkempt condition and smokebox char on the running plate! I don't think the NRM will be recreating this in the future - more's the pity.
I don't think I've seen another preserved steam engine with such an authentic air as this.
On this very grey rainy day I had the privilege to drive it at the Llangollen Railway although in those days I had to pay like everyone else. The rain poured down all day but nothing could dampen my enjoyment of the experience.
Southern Strobist Club meet 18th April 2010 @ California Barn, Swanage, UK
Model - Emma Sutton
MUA's Racheal Platt ,Nicola Redman , Kristie Moles
Big thanks to Lotty for supplying all the wonderfull clothes.
Nikon D300 (manual, Srgb) iso 200 f/5.6 1/250th
Lens Nikon 24-70mm f/2.8 (DX=62mm (FX=93mm))
Elinchrom Quadra fitted with a 1m Rotalux softbox with diffuser
as main key light to right of model. power adjusted to achieve
an f/5.6 stop. Rotalux also fitted with Gold deflector
SB-800 set behind model within the barn and gridded to give a slight hair light
Lastolite Tri-Flip with sunfire reflector used to add some colour/tone to the models
Face...
All triggered via elinchrom skyport.
Sekonic Flash master L-358 used to take the light measurements....
Post Edit in Photoshop CS4
Many thanks to Howard from Southern strobists for setting the event up and the many models and MUA's for all the hard work & my two team mates Andy & Graham for making the day a buzz.......
Strobist Info:
Single 580EX II in a Westcott RapidBox Duo at 1/2 power, 24mm zoom, on camera axis, supported by a Manfrotto 420B boom. Deflector plate, inner baffle, outer diffuser and egg crate grid in place. Yongnuo YN622C-TX trigger.
Thunder Gray seamless background lit by a Single 580EX at full power, 24mm zoom with a 45 degree Rogue Grid and Steel Green gel, on the floor behind the subject.
After a day of hard work I took Sera Yosta, my most beautiful lens and my Elinchrom light outside to the streets of Amsterdam, just to see what light can do. The temperature was quite high here in The Netherlands, 14 degrees Celcius in mid-december! So, the perfect moment to make some simple clicks.
As light I used the ELB400 & Elinchrom Deep Octa with translucent deflector and inner diffuser.
Lens: Canon EF 85mm f/1.2L II USM on full frame.
Hans van Eijsden Photography, The Netherlands
Postprocessing: Some local adjustment curves.
Portfolio: www.hansvaneijsden.com
Facebook Page: www.facebook.com/hansvaneijsdenphotography
“A Short History of Nearly Everything” ―Bill Bryson, 2003
“Not one of your pertinent ancestors was squashed, devoured, drowned, starved, stranded, stuck fast, untimely wounded, or otherwise deflected from its life's quest of delivering a tiny charge of genetic material to the right partner at the right moment in order to perpetuate the only possible sequence of hereditary combinations that could result -- eventually, astoundingly, and all too briefly -- in you.”